SPACInsider•7 days ago
Cingulate Inc. is a clinical-stage biopharmaceutical company developing treatments for attention deficit/hyperactivity disorder. The company's lead candidates are CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). CTx-2103 is being developed for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, KS.
What is Cingulate's quote symbol?
What is the 52 week high and low for Cingulate (NASDAQ: CING)?
How much is Cingulate stock worth today?
How much is Cingulate's stock price per share?
What is Cingulate's Market Cap?